Cencora, Inc.
Market cap $60.3B
$309.89
COR
$309.89
+1.58% today
Buy with €1M virtual cash · No real money
Cencora, Inc. (COR) is a publicly traded company listed on the XNYS. As of July 27, 2026, Invest's signal rates COR a Hold, with the stock up 6% over the past year. You can practice trading COR risk-free with €1,000,000 in virtual cash.
Key stats
As of July 27, 2026
Market Cap
$60.3B
Volume
852K
52-wk High
$377.54
52-wk Low
$244.82
Day High
$310.30
Day Low
$304.25
P/E (TTM)
23.75
Revenue (TTM)
$328.7B
EPS (TTM)
$13.05
Performance
1M
+8.9%
6M
-12.1%
1Y
+5.6%
Invest signal · COR
HoldAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
COR overview
AI overviewRevenue & EPS — last 8 quarters
QoQ rev -8.8%Revenue
$78BEPS (diluted)
$8.40 per shareLatest COR news
COR Investors Have Opportunity to Join Cencora, Inc. Fraud Investigation with the Schall Law Firm
GlobeNewswire Inc. · May 18
Cencora Lifts 2026 Sales Outlook Despite Q1 Revenue Miss
Benzinga · Feb 4
Comparator Drug Sourcing Market to Reach USD 2.72 Billion by 2033, Driven by Rising Global Clinical Trials and Outsourcing Trends – SNS Insider
GlobeNewswire Inc. · Jan 23
AOP Health’s Rapiblyk™ Now Accessible via Leading US Healthcare Improvement Companies
GlobeNewswire Inc. · Jan 12
Cencora Strikes $5 Billion OneOncology Deal, Pauses Stock Buyback
Benzinga · Dec 15
About Cencora, Inc.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry.
Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Employees
51,000
30-Day Win Rate · COR
14 days
9 days
Last 23 sessions
How to practice trading COR
- 1
Use the COR buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top COR traders on Invest
Full leaderboardFrequently asked questions
Is COR a good stock to buy right now?
As of July 27, 2026, Invest's signal rates COR a Hold, based on its price trend, valuation, and fundamentals (P/E around 23.7), with the stock up 6% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading COR risk-free first.
What is Cencora, Inc.'s (COR) market cap?
Cencora, Inc. has a market capitalization of approximately $60.3B, on trailing-twelve-month revenue of about $328.7B.
How has COR stock performed?
COR is up 6% over the past year and down 12% over six months. Its 52-week range runs roughly from $244.82 to $377.54. Past performance doesn't predict future results.
How can I practice trading COR for free?
On Invest you get €1,000,000 in virtual cash and can buy COR at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare COR with peers